We are dedicated to funding scientific research because the link between research spending and improved survival is clear. Our strategic investment in both early detection and therapeutics will help people live better with lung cancer and dramatically improve on the current 19% five-year survival rate.
LUNGevity initiatives position us as thought leaders in the lung cancer advocacy community, providing programs and driving change for those with lung cancer today and in the future. While we fund primary research, we also conduct patient-focused research to better understand their unmet needs and convene multi-stakeholder meetings to streamline the research process and accelerate progress to patients.
LUNGevity seeks to empower patients to be active decision makers in their treatment process through our extensive educational resources, online peer-to-peer support, and in-person survivorship programs.